Chinese COVID-19 Vaccine Generates Antibodies in Clinical Trials

Read Time:24 Seconds

The Chinese pharmaceutical company, Sinopharm, is developing a COVID-19 vaccine that is showing the generation of antibodies in its early trials in China. Since China does not have many new cases, the vaccine is also being tested in the United Arab Emirates and will be tested in Brazil. The virus has killed over 750,000 people in the entire world, which triggered a race between the pharmaceutical companies around the world to develop a vaccine.

Source: UOL

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
24950cookie-checkChinese COVID-19 Vaccine Generates Antibodies in Clinical Trials